Nutex Health Inc. (NASDAQ:NUTX) Short Interest Update

Nutex Health Inc. (NASDAQ:NUTXGet Free Report) was the target of a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 54,400 shares, a growth of 86.9% from the January 31st total of 29,100 shares. Based on an average trading volume of 40,600 shares, the short-interest ratio is currently 1.3 days. Currently, 1.7% of the shares of the stock are sold short.

Analyst Ratings Changes

Several equities research analysts recently issued reports on NUTX shares. Maxim Group lifted their price objective on Nutex Health from $50.00 to $75.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Benchmark increased their target price on Nutex Health from $45.00 to $60.00 and gave the company a “buy” rating in a research note on Tuesday, November 12th.

Get Our Latest Report on NUTX

Hedge Funds Weigh In On Nutex Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE raised its holdings in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after buying an additional 2,043 shares during the last quarter. Beaird Harris Wealth Management LLC purchased a new position in shares of Nutex Health in the third quarter valued at about $69,000. International Assets Investment Management LLC bought a new position in shares of Nutex Health during the third quarter valued at about $188,000. Northern Trust Corp purchased a new stake in shares of Nutex Health during the fourth quarter worth about $200,000. Finally, Baader Bank Aktiengesellschaft bought a new stake in shares of Nutex Health in the fourth quarter worth about $206,000. 5.32% of the stock is currently owned by institutional investors.

Nutex Health Stock Up 1.6 %

Shares of NASDAQ:NUTX opened at $54.90 on Friday. The stock has a market capitalization of $298.49 million, a P/E ratio of -5.85 and a beta of 0.20. The stock’s 50-day moving average price is $44.89 and its 200-day moving average price is $32.29. The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. Nutex Health has a 12-month low of $4.16 and a 12-month high of $69.45.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Featured Stories

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.